Not Tagged
Not Tagged
['aml,(-streamline),(-seamless),(-kamloops)', 'mds']
results of the intact trial presented today at #asco2022 - excellent outcomes in aml/high risk mds patients given prophylatic t cells targeting tumour antigens wt1 and prame, and multipathogens post #allotransplant. 
Haematologist | PhD Researcher | Humanist | Musician | Stem Cell Transplantation | Cellular Therapies | HSANZ/Leukaemia Foundation PhD Scholar